Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

336
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
336
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

586
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
586
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

50
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
50
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

3
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
3
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

85
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
85
Vascular Spasm01:16

Vascular Spasm

1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nomogram and scoring models based on BMI z-score, serum chlorine and urine specific gravity levels for predicting oral rehydration solution efficacy in pediatric postural orthostatic tachycardia syndrome.

World journal of pediatrics : WJP·2025
Same author

Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024).

World journal of pediatrics : WJP·2024
Same author

Age and mean platelet volume-based nomogram for predicting the therapeutic efficacy of metoprolol in Chinese pediatric patients with vasovagal syncope.

World journal of pediatrics : WJP·2024
Same author

Insights into postural orthostatic tachycardia syndrome after COVID-19 in pediatric patients.

World journal of pediatrics : WJP·2024
Same author

Baroreflex sensitivity and its implication in neurally mediated syncope in children.

World journal of pediatrics : WJP·2023
Same author

A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome.

World journal of pediatrics : WJP·2023

Related Experiment Video

Updated: Jun 12, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

20.7K

Malignant vasovagal syncope in children.

Wen-Rui Xu1, Hong-Fang Jin1,2, Jun-Bao Du3,4

  • 1Department of Pediatrics, Children's Medical Center, Peking University First Hospital, No. 8, Xishiku Street, West District, Beijing, 100034, China.

World Journal of Pediatrics : WJP
|December 18, 2024
PubMed
Summary
This summary is machine-generated.

Malignant vasovagal syncope (VVS) in children is a serious condition involving prolonged asystole. Understanding its causes and effective treatments requires further investigation due to limited current research.

Keywords:
AsystoleDiagnosisPathogenesisPediatricsTreatmentVasovagal syncope

More Related Videos

Measuring Cardiac Autonomic Nervous System ANS Activity in Children
09:45

Measuring Cardiac Autonomic Nervous System ANS Activity in Children

Published on: April 29, 2013

20.9K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

941

Related Experiment Videos

Last Updated: Jun 12, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

20.7K
Measuring Cardiac Autonomic Nervous System ANS Activity in Children
09:45

Measuring Cardiac Autonomic Nervous System ANS Activity in Children

Published on: April 29, 2013

20.9K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

941

Area of Science:

  • Pediatric Cardiology
  • Neurology
  • Syncope Syndromes

Background:

  • Malignant vasovagal syncope (VVS) is a distinct cardioinhibitory VVS subtype.
  • It is characterized by prolonged asystole in pediatric patients.
  • This review focuses on malignant VVS in children.

Purpose of the Study:

  • To review advancements in understanding malignant VVS in children.
  • To explore potential pathogenesis, diagnostics, clinical significance, and treatment controversies.
  • To address the limited current knowledge on pediatric malignant VVS.

Main Methods:

  • Literature review of studies up to September 2024.
  • Databases searched include PubMed and Chinese Journal Full-text Database.
  • Search terms focused on "malignant vasovagal syncope" and "children" or "vasovagal syncope" with "asystole" and "children".

Main Results:

  • Studies on malignant VVS in children are limited.
  • Children with malignant VVS may be at risk of physical or mental impairment.
  • The mechanism of cardiac inhibition and optimal treatment strategies remain unclear.

Conclusions:

  • Current understanding of malignant VVS in children is insufficient.
  • Further research is needed on clinical features and pathogenesis.
  • Effective management strategies for pediatric malignant VVS require development.